A detailed history of Swiss National Bank transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Swiss National Bank holds 96,600 shares of EYPT stock, worth $685,860. This represents 0.0% of its overall portfolio holdings.

Number of Shares
96,600
Previous 93,100 3.76%
Holding current value
$685,860
Previous $809,000 4.7%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$7.58 - $10.54 $26,530 - $36,890
3,500 Added 3.76%
96,600 $771,000
Q2 2024

Aug 08, 2024

BUY
$8.16 - $22.89 $52,224 - $146,496
6,400 Added 7.38%
93,100 $809,000
Q1 2024

May 07, 2024

BUY
$19.93 - $29.71 $1.73 Million - $2.58 Million
86,700 New
86,700 $1.79 Million

Others Institutions Holding EYPT

About EyePoint Pharmaceuticals, Inc.


  • Ticker EYPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,072,200
  • Market Cap $242M
  • Description
  • EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...
More about EYPT
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.